Injectable vitamin formulations recalled due to facility sterility concerns
Pharmacy Innovations is recalling three injectable vitamin formulations due to insanitary facility conditions identified during FDA inspection that may affect product sterility.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall involving injectable products with potential sterility issues due to insanitary facility conditions. Although the product category carries inherent risk due to direct injection route, no illnesses or injuries have been reported, and the hazard is theoretical rather than confirmed contamination.
Plain-English summary
Pharmacy Innovations, located at 2936 W 17th St., Erie, PA, is recalling three injectable vitamin formulations due to insanitary conditions discovered during a U.S. Food and Drug Administration inspection. The affected products contain combinations of methionine, inositol, choline, and B vitamins in 1 mL vials.
The recalled formulations include Cyanocobalamin (25 mg/50 mg/50 mg/1 mg/mL), Methylcobalamin (15 mg/50 mg/100 mg/1 mg/mL), and Riboflavin/Niacinamide/Pyridoxine/Ascorbic Acid formulations. Affected lot numbers are t20221011@25, t20221025@48, and t20221115@36, distributed nationwide.
The FDA inspection revealed insanitary conditions at the manufacturing facility that may have affected the sterility assurance of these injectable products. No illnesses or adverse events have been reported.
Healthcare providers and patients should discontinue use of recalled products and consult their healthcare provider about alternatives. Distributors and healthcare facilities should quarantine recalled product and cease distribution.
The recalled product
- Product
- METHION/INOSIT/CHOLINE/CYANOCOBAL 25MG/50MG/50MG/1MG/ML (1ML VIAL) INJECTABLE; METHION/INOSIT/CHOLINE/METHYLCOBAL 15MG/50MG/100MG/1MG/ML (1ML VIAL) INJECTABLE; METHION/INOSIT/CHOLINE/RIBOFLA/NIACINAMIDE/PYRIDOX/ASCORBIC ACID 15.625MG/31.25MG/31.25MG/6.25MG/62.5MG/6.25MG/62.5MG/ML
- Manufacturer
- Pharmacy Innovations
- Category
- Drug — Injectable Vitamins
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- t20221011@25 t20221025@48 t20221115@36
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 59 recalled by Pharmacy Innovations under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 59 products in this recall →Related recalls
Same manufacturer · Pharmacy Innovations
See all →- HighEdetate Disodium Ophthalmic Solution Recalled for Sterility Concerns
FDA (Drugs) · 2023-02-01
- HighInjectable Hydroxocobalamin Recalled Due to Sterility Assurance Failure
FDA (Drugs) · 2023-02-01
- HighFDA Recalls Acetylcysteine Ophthalmic Solution Due to Sterility Concerns
FDA (Drugs) · 2023-02-01
- HighMethylcobalamin Injectable Recall Due to Facility Sterility Assurance Failure
FDA (Drugs) · 2023-02-01
- HighInjectable vitamin B-complex products recalled for lack of sterility assurance
FDA (Drugs) · 2023-02-01
Same hazard · sterility assurance
See all →- HighArrowhead DE LLC Recalls Arrow-LOK Implants Due to Sterility Assurance Concerns
FDA (Devices) · 2026-08-26
- SevereChloraPrep One-Step Applicators Recalled for Potential Packaging Seal Defects
FDA (Drugs) · 2026-07-22
- SeverePemetrexed for Injection Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15
- SevereChloraPrep One-Step Applicators Recalled Due to Sterility Assurance Failure
FDA (Drugs) · 2026-07-08
- SevereArrow drainage and thoracentesis kits contain recalled supplier drugs
FDA (Devices) · 2026-06-24